SE7604052L - Nya erytromycinderivat och forfarande for framstellning derav - Google Patents

Nya erytromycinderivat och forfarande for framstellning derav

Info

Publication number
SE7604052L
SE7604052L SE7604052A SE7604052A SE7604052L SE 7604052 L SE7604052 L SE 7604052L SE 7604052 A SE7604052 A SE 7604052A SE 7604052 A SE7604052 A SE 7604052A SE 7604052 L SE7604052 L SE 7604052L
Authority
SE
Sweden
Prior art keywords
procedures
manufacture
erythromycin derivatives
new erythromycin
new
Prior art date
Application number
SE7604052A
Other languages
English (en)
Other versions
SE425566B (sv
Inventor
R Maier
E Woitun
B Wetzel
W Reuter
H Goeth
U Lechner
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25768725&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE7604052(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE2515075A external-priority patent/DE2515075C2/de
Priority claimed from DE19762606030 external-priority patent/DE2606030A1/de
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of SE7604052L publication Critical patent/SE7604052L/sv
Publication of SE425566B publication Critical patent/SE425566B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65586Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
SE7604052A 1975-04-07 1976-04-06 Forfarande for framstellning av erytromycinderivat och syraadditionssalter derav SE425566B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2515075A DE2515075C2 (de) 1975-04-07 1975-04-07 Erythromycinderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE19762606030 DE2606030A1 (de) 1976-02-14 1976-02-14 Neue erythromycinderivate und verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
SE7604052L true SE7604052L (sv) 1976-10-08
SE425566B SE425566B (sv) 1982-10-11

Family

ID=25768725

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7604052A SE425566B (sv) 1975-04-07 1976-04-06 Forfarande for framstellning av erytromycinderivat och syraadditionssalter derav

Country Status (29)

Country Link
US (1) US4048306A (sv)
JP (1) JPS51128991A (sv)
AT (1) AT342770B (sv)
AU (1) AU498418B2 (sv)
BG (1) BG27380A3 (sv)
CA (1) CA1060005A (sv)
CH (2) CH621800A5 (sv)
CS (1) CS196304B2 (sv)
DD (1) DD125218A5 (sv)
DK (1) DK138656C (sv)
ES (2) ES446737A1 (sv)
FI (1) FI63244C (sv)
FR (1) FR2306703A1 (sv)
GB (1) GB1520963A (sv)
GR (1) GR60374B (sv)
HU (1) HU175186B (sv)
IE (1) IE43598B1 (sv)
IL (1) IL49359A (sv)
LU (2) LU74702A1 (sv)
MX (1) MX3277E (sv)
NL (1) NL180107C (sv)
NO (1) NO141411C (sv)
NZ (1) NZ180529A (sv)
PL (1) PL101880B1 (sv)
PT (1) PT64977B (sv)
RO (1) RO68441B (sv)
SE (1) SE425566B (sv)
SU (1) SU682134A3 (sv)
YU (1) YU87676A (sv)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT42502A (en) 1985-03-12 1987-07-28 Beecham Group Plc Process for preparing new erythromycine derivatives
DE3524572A1 (de) * 1985-07-10 1987-01-15 Thomae Gmbh Dr K Feste arzneimittelformen zur peroralen anwendung enthaltend 9-deoxo-11-deoxy-9,11-(imino(2-(2-methoxyethoxy)ethyliden)-oxy)-(9s)-erythromycin und verfahren zu ihrer herstellung
US5110800A (en) * 1986-02-18 1992-05-05 Eli Lilly And Company Derivatives of erythromycylamine
US4945080A (en) * 1987-05-26 1990-07-31 Eli Lilly And Company Dirithromycin metabolite
US5075289A (en) * 1988-06-07 1991-12-24 Abbott Laboratories 9-r-azacyclic erythromycin antibiotics
KR0166096B1 (ko) * 1990-11-28 1999-01-15 우에하라 아키라 6-0-메틸에리쓰로마이신 a 유도체
US5556839A (en) * 1991-04-29 1996-09-17 Eli Lilly And Company Form II Dirithromycin
ZA922777B (en) * 1991-04-29 1993-10-15 Lilly Co Eli Pharmaceutical formulation containing dirithromycin
MY113261A (en) * 1991-09-30 2002-01-31 Lilly Co Eli One step process for production of dirithromycin.
DE4410637C1 (de) * 1994-03-26 1995-09-21 Boehringer Ingelheim Vetmed Injizierbare Lösungen von Dirithromycin
WO1999021867A1 (fr) * 1997-10-29 1999-05-06 Taisho Pharmaceutical Co., Ltd. Derives d'erythromycine a
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US6565882B2 (en) 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
US6541014B2 (en) 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US6436906B1 (en) 2001-04-02 2002-08-20 Enanta Pharmaceuticals, Inc. 9-amino-14-membered macrolides derived from leucomycins
JP2006528185A (ja) 2003-07-21 2006-12-14 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
US8313776B2 (en) 2003-07-21 2012-11-20 Shionogi Inc. Antibiotic product, use and formulation thereof
US8313775B2 (en) 2003-07-21 2012-11-20 Shionogi Inc. Antibiotic product, use and formulation thereof
WO2005016311A1 (en) 2003-08-11 2005-02-24 Advancis Pharmaceutical Corporation Robust pellet
JP2007502294A (ja) 2003-08-12 2007-02-08 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
EP1658034A4 (en) * 2003-08-29 2011-06-22 Middlebrook Pharmaceuticals Inc ANTIBIOTIC PRODUCT, ITS USE AND FORMULATION
JP2007513869A (ja) 2003-09-15 2007-05-31 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
JP2008505124A (ja) 2004-07-02 2008-02-21 アドバンシス ファーマスーティカル コーポレイション パルス送達用錠剤
US8778924B2 (en) 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8299052B2 (en) * 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3660376A (en) * 1970-09-30 1972-05-02 Lilly Co Eli N-arylidene erythromycylamines

Also Published As

Publication number Publication date
US4048306A (en) 1977-09-13
AU498418B2 (en) 1979-03-15
AU1272276A (en) 1977-10-13
ES446737A1 (es) 1977-10-16
HU175186B (hu) 1980-05-28
DK138656B (da) 1978-10-09
ES456567A1 (es) 1978-03-01
FI760845A (sv) 1976-10-08
SU682134A3 (ru) 1979-08-25
NL7603569A (nl) 1976-10-11
NO761172L (sv) 1976-10-08
LU88563I2 (fr) 1995-03-21
FI63244B (fi) 1983-01-31
ATA149976A (de) 1977-08-15
FR2306703A1 (fr) 1976-11-05
NO141411B (no) 1979-11-26
GB1520963A (en) 1978-08-09
JPS51128991A (en) 1976-11-10
IL49359A0 (en) 1976-06-30
PT64977B (de) 1978-04-03
NO141411C (no) 1980-03-05
AT342770B (de) 1978-04-25
YU87676A (en) 1982-08-31
PT64977A (de) 1976-05-01
PL101880B1 (pl) 1979-02-28
NZ180529A (en) 1978-09-20
DK138656C (da) 1979-04-02
MX3277E (es) 1980-08-15
DK145276A (da) 1976-10-08
CH621800A5 (sv) 1981-02-27
CA1060005A (en) 1979-08-07
IL49359A (en) 1979-07-25
NL180107B (nl) 1986-08-01
IE43598L (en) 1976-10-07
DD125218A5 (de) 1977-04-06
CS196304B2 (en) 1980-03-31
LU74702A1 (sv) 1977-06-03
RO68441B (ro) 1983-04-30
CH624413A5 (sv) 1981-07-31
BG27380A3 (en) 1979-10-12
RO68441A (ro) 1983-04-29
FI63244C (fi) 1983-05-10
NL180107C (nl) 1987-01-02
GR60374B (en) 1978-05-23
IE43598B1 (en) 1981-04-08
JPS62158B2 (sv) 1987-01-06
SE425566B (sv) 1982-10-11
FR2306703B1 (sv) 1979-10-12

Similar Documents

Publication Publication Date Title
SE7604052L (sv) Nya erytromycinderivat och forfarande for framstellning derav
SE7612366L (sv) Nya hydroxibensylmalonsyra-derivat.
AR213097A1 (es) Procedimiento para preparar derivados de la 1,4-dihidropirina
SE416298B (sv) Forfarande for framstellning av nya bensimidazolinon derivat
SE7707689L (sv) 2-brom-6-fluor-n-2-imidazolidinylidenbensamin dess syraadditionssalter, lekemedel innehallande dessa och forfarande for framstellning derav
SE7411243L (sv)
SE7609495L (sv) N-tetrahydrofurfuryl-noroximorfon, dess syraadditionssalter, lekemedel innehallande dessa samt forfarande for framstellning derav
SE402009B (sv) Forfarande for framstellning av 9-desoxi-prosta-5,9,(10),13-triensyraderivat
AR211856A1 (es) Procedimiento para producir derivados de 5-metil-1-fenil-1,3,4,6,-tetrahidro-5h-benzf2,5,-oxazocina
SE7512857L (sv) Nya konoaxalin-1,4-dioxidderivat jemte sett for deras framstellning
ES449688A1 (es) Procedimiento para la preparacion de un acido 7-(alfa-amino-w-(3, 4-metilenodioxifenil) acilamido) cefalosporanico.
ES449991A1 (es) Procedimiento para la preparacion de derivados de acido 7 (alfaamino-omega-(2,3-metilenodioxifenil y acilamido) cefa- losporanico.
MX4655E (es) Procedimiento para preparar derivados del acido 3,3,'-triarilmetanodicarboxilico
SE7606318L (sv) Nya tienyl-prostaglandiner och forfarande for deras framstellning
ZA761859B (en) Novel substituted sulfonamide derivatives as anthelmintic agents
AR219072A1 (es) Procedimiento para preparar nuevos derivados de(piridil-3-imino)-3-tetrahidro 1,5,10,10a-tiazol(3,4-b)-isoquinoleina
BE848118A (fr) Procede de production d'un compose extincteur,
AR212174A1 (es) Procedimiento para la preparacion de derivados de las 1-aminometil-6,7-dihidroxi-1,2,3,4-tetrahidroisoquinoleinas
SE7606592L (sv) Nya aminobensoesyraderivat, forfarande for framstellning derav och farmaceutiska kompositioner innehallande dessa
MX4457E (es) Procedimiento mejorado para la preparacion de derivados substituidos de 2h-piran-2,6(3h)-diona
SE7601097L (sv) Piperidinderivat
IT1055240B (it) Procedimento per la produzione di composizioni antitraspiranti
BE842740A (fr) Procede de preparation de derives de substitution de la 1,2,4 oxadiazoline-3-one
AR204011A1 (es) Procedimiento de preparacion de nuevos derivados de 7-h-indolizino(5,6,7-ij)isoquinoleina
AR210879A1 (es) Procedimiento de preparacion de derivados de acido 2,3-dioxo-1-piperazinocarboinil-amion -cecefem-4-carboxilico

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7604052-6

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7604052-6

Format of ref document f/p: F